Structure of Amentoflavone
CAS No.: 1617-53-4
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Amentoflavone is an inhibitor of human UDP-glucuronosyltransferases with anti-inflammatory, antioxidative, and neuroprotective effects and it can be isolated from the seeds of Ginkgo biloba L. Amentoflavone inhibited SARS-CoV 3CL(pro) with IC50 value of 8.3μM.
Synonyms: Didemethyl-ginkgetin; NSC 295677; 38Biapigenin
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Enhancing the anticancer effects of Apiaceae spice phytochemicals.
Scott, Jared Lee ;
Abstract: Breast cancer (BC) is the second greatest contributor to the death of women, second only to heart disease, and is the most common type of cancer. BC treatments involve the administration of adjuvant chemotherapies which often have side effects that prevent patients from completing the full course of drugs or the refusal to take these potentially lifesaving treatments. Many chemotherapy drugs are developed from plants, and some plant extracts can exhibit significant anticancer activities while also having less toxic side effects. However, these potential "plant therapeutics" suffer from poor oral bioavailability. The Apiaceae plant family consists of several species that are used as culinarily spices including anise, celery, cumin, and coriander, all of which have demonstrated antioxidant, chemopreventive, and anticancer activities. One method to improve the systemic distribution of anticancer phytochemicals is their encapsulation in naturally produced membrane bound nanoparticles known as exosomes. Exosomes are produced by most eukaryotic organisms, as well as some prokaryotes, and are involved in cell-to-cell communication through the delivery of proteins, nucleic acids, and small molecules from one cell to another. Exosomes are found in many extracellular fluids including blood, urine, and milk. Bovine milk exosomes represent a scalable source of exosomes that are already present in the human diet and have been explored as a drug delivery system that can increase effectiveness and improve bioavailability. To enhance the loading potential and anticancer bioactivity of Apiaceae phytochemicals, an acid hydrolysis (AH) of the glycoside compounds present in ethanolic spice extracts was performed on eight ethanolic spice extracts. The antiproliferative effects of AH extracts and exosomal formulations were assayed with three model types of BC cells. Cumin was characterized in greater detail as these extracts had the highest concentration of terpenoids and alkaloids while also having significant concentrations of phenolics and responded well to AH with increased antiproliferative activity and exosomal loading. Extracts and exosomal formulations exhibited broad antiproliferative effects with lower IC50s in the extracts delivered with exosomes. The phytochemical contents of AH-cumin extracts and exosomal formulations were assayed with HPLC-DAD, LC-MS/MS, and GC-MS, while the potential anticancer mechanisms of these treatments were investigated in triple negative BC (TNBC). AHcumin extracts were determined to have numerous phenolic compounds, many of which have known anticancer mechanisms, in addition to several alkaloids and lipid compounds, some of which have activities that could contribute to the anticancer effects observed. Mechanistically, AH-cumin extracts and exosomal formulations were shown to interact with multidrug resistance proteins and inhibit lipid metabolism in TNBC cells. These results indicate that acid hydrolyzed cumin extracts delivered through exosome nanoparticles represent a possible avenue towards the development of novel treatments for TNBC, the hardest type of BC to treat.
Show More >
CAS No. : | 1617-53-4 |
Formula : | C30H18O10 |
M.W : | 538.46 |
SMILES Code : | O=C1C=C(C2=CC=C(O)C=C2)OC3=C(C4=CC(C5=CC(C6=C(O)C=C(O)C=C6O5)=O)=CC=C4O)C(O)=CC(O)=C13 |
Synonyms : |
Didemethyl-ginkgetin; NSC 295677; 38Biapigenin
|
MDL No. : | MFCD00017470 |
InChI Key : | YUSWMAULDXZHPY-UHFFFAOYSA-N |
Pubchem ID : | 5281600 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P280-P301+P312-P302+P352-P305+P351+P338 |
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
3T3-L1 pre-adipocytes | 1-10 µg/ml | 0-8, 0-2, 2-4, 4-8 days | AMF inhibited 3T3-L1 adipocyte differentiation, reduced oil droplet accumulation, and suppressed the expression of C/EBPβ, PPARγ, and C/EBPα. | PMC5117752 |
BV2 microglial cells | 10 μM | 1 hour | Amentoflavone inhibited LPS-induced microglial activation, migration, and inflammatory response by regulating the TLR4/MyD88/NF-κB pathway and enhanced Nrf2/HO-1 levels | PMC9747320 |
A549 cells | 30 μg/mL | 1 hour, 2 hours, 4 hours, and 6 hours | To evaluate the cellular uptake of AMF and AMF-loaded TPGS/soluplus mixed micelles in A549 cells. The results showed that the cellular uptake of AMF monomer increased significantly with time, while that of AMF-loaded mixed micelles increased in 1-4 hours and remained almost unchanged in 4-6 hours. The cellular uptake of AMF-loaded mixed micelles was significantly lower than that of AMF monomer (p<0.05). | PMC6968485 |
A549 cells | 0.5-4 µg/mL | 2 hours | To evaluate the protective effect of AMF against AerA-mediated cytotoxicity, results showed that AMF significantly reduced AerA-mediated cell death. | PMC11900166 |
A549 cells | 2000 μg/mL to 15.6 μg/mL | 24 hours | To evaluate the cytotoxicity of AMF and AMF-loaded TPGS/soluplus mixed micelles on A549 cells. The results showed that the IC50 value of AMF-loaded mixed micelles (6.11 ± 0.74 μg/mL) was significantly lower than that of AMF monomer (83.09 ± 0.65 μg/mL), indicating that the mixed micelles had stronger toxicity to A549 cells. | PMC6968485 |
A549 cells | 0, 10, 25, 50 µM | 24 hours | Evaluate the inhibitory effect of AF on influenza virus infection, results showed AF dose-dependently inhibited GFP expression. | PMC11595079 |
RAW 264.7 cells | 0, 10, 25, 50 µM | 24 hours | Evaluate the inhibitory effect of AF on influenza virus infection, results showed AF dose-dependently inhibited GFP expression. | PMC11595079 |
Human umbilical vein endothelial cells (HUVECs) | 18.587 μM | 24 hours | To evaluate the cytoprotective effects of Amentoflavone on LPS-induced injury in HUVECs. Results showed that Amentoflavone significantly reduced NO and MDA levels and increased SOD activity, indicating its protective effects against inflammation and oxidative damage. | PMC5037791 |
HK-2 cells | 1 or 2 μM | 24 hours | AME significantly suppressed the cytotoxic effects of cisplatin on HK-2 cells and protected cells from oxidative stress by activating the Nrf2 antioxidant pathway. | PMC11919867 |
MHCCLM3 cells | 100, 200, 300 μM | 24 hours | Amentoflavone inhibits the migratory and invasive capabilities of HCC cells in a dose-dependent manner | PMC11154840 |
MHCC97H cells | 100, 200, 300 μM | 24 hours | Amentoflavone inhibits the migratory and invasive capabilities of HCC cells in a dose-dependent manner | PMC11154840 |
Immortalized astrocytes | 2, 10 µM | 3 hours | To evaluate the effect of Amentoflavone on the cellular uptake of Aβ1-40 in astrocytes, results showed that Amentoflavone significantly increased the intracellular accumulation of Aβ1-40. | PMC9180170 |
HepG2 cells | 9.30 μM, 13.94 μM, 18.59 μM | 36 hours | To explore the mechanism by which AME improves insulin resistance in HepG2 cells. Results showed that AME significantly increased glucose consumption, upregulated the expression of PI3K, Akt, and pAkt, enhanced the activities of PFK-1, GCK, and PK, and reduced the activities of GSK-3, PEPCK, and G-6-Pase as well as the levels of IL-6, IL-8, TNF-α, and CRP. | PMC6274486 |
Endometrial carcinoma cells (KLE) | 50, 75, 100 μM | 48 hours | AF inhibited the viability and proliferation of KLE cells but promoted apoptosis and ferroptosis. | PMC9275900 |
BV2 microglial cells | 10 μM | 5.5 hours | Amentoflavone alleviates LPS-induced inflammatory response by inhibiting NLRP3 inflammasome | PMC6682693 |
Human epithelial colorectal adenocarcinoma (Caco2) cells | 2-16 mg/ml | 6 hours | Evaluate the protective effect of Amentoflavone on CPA and PFO-mediated cytotoxicity, results showed significant protection against cell injury | PMC7059699 |
Human epithelial colorectal adenocarcinoma (Caco2) cells | 0 -64 mg/ml | 6 hours | Evaluate the cytotoxicity of Amentoflavone on Caco-2 cells, results showed no cytotoxicity | PMC7059699 |
MDCK cells | 0, 10, 50 µM | 72 hours | Evaluate the inhibitory effect of AF on influenza virus plaque formation, results showed AF significantly inhibited plaque formation. | PMC11595079 |
BALB/c mouse peritoneal macrophages | 0–22.3 µM | 72 hours | Evaluate the cytotoxicity of Amentoflavone, no cytotoxicity was observed, and the selectivity index was greater than 10 | PMC7950538 |
BALB/c mouse peritoneal macrophages | 0–11.14 µM | 72 hours | Evaluate the antileishmanial activity of Amentoflavone on intracellular amastigotes, IC50 was 2.3 ± 0.93 µM | PMC7950538 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
Wistar rats | High-fat diet-induced metabolic dysfunction model | Intraperitoneal injection | 10 or 50 mg/kg | Once daily for 4 months | AMF attenuated high-fat diet-induced metabolic dysfunction in a dose-dependent manner, including reductions in fasting blood glucose, fasting insulin levels, HOMA-IR index, body weight, perirenal adipose tissue weight, and serum triglyceride content. | PMC5117752 |
Kunming mice | Epilepsy model | Intragastric administration | 25 mg/kg | Once a day for 3 consecutive days | Amentoflavone effectively prevented pilocarpine-induced epilepsy in a Mice kindling model, suppressed nuclear factor-κB activation and expression, inhibited excessive discharge of hippocampal neurons resulting in a reduction in epileptic seizures, shortened attack time, and diminished loss and apoptosis of hippocampal neurons. | PMC4541246 |
BALB/c mice | Leishmaniasis model | Intralesional injection | 0.05 mg/kgose | Every 4 days, total of 5 doses | Evaluate the therapeutic effect of Amentoflavone on leishmaniasis, intralesional treatment significantly reduced lesion size and parasite load | PMC7950538 |
Channel catfish | Aeromonas hydrophila infection model | Intraperitoneal injection | 20 mg/kg | Every 12 hours for 3 days | To evaluate the protective effect of AMF against A. hydrophila infection, results showed that the mortality rate in the AMF-treated group was reduced by 35% compared to the positive control group. | PMC11900166 |
C57BL/6 mice | PTZ-induced chronic epilepsy model | Oral | 25 mg/kg | Once every other day for a total of 15 injections (29 days) | Amentoflavone reduces seizure susceptibility, minimizes cognitive dysfunction, and blocks neuronal apoptosis by inhibiting NLRP3 inflammasome | PMC6682693 |
C57BL/6 mice | Cisplatin-induced acute kidney injury model | Intraperitoneal injection | 5 or 10 mg/kg | Daily administration for 72 hours | AME significantly improved cisplatin-induced acute kidney injury by activating the Nrf2 antioxidant pathway and regulating ferroptosis and PANoptosis. | PMC11919867 |
BALB/c mice | Gas gangrene model | Subcutaneous injection | 50 mg/kg | Three doses at 8-hour intervals | Evaluate the therapeutic effect of Amentoflavone on gas gangrene, results showed significant increase in survival rate, reduction in bacterial burden in tissues, and alleviation of histological damage | PMC7059699 |
Mice | Carrageenan-induced pleurisy and lung injury model | Intragastric administration | 30 mg/kg or 50 mg/kg | Administered at 12-hour intervals for 4 hours | AMF ameliorated carrageenan-induced pleurisy and lung injury by activating Nrf2 and inhibiting the NF-κB and STAT3 pathways | PMC8883043 |
Mice | Diabetic mice induced by high fat diet and streptozotocin | Intragastric administration | 20 mg/kg and 40 mg/kg | 8 weeks | AME exerted anti-diabetic effects by regulating glucose and lipid metabolism, perhaps via anti-oxidant effects and activating the PI3K/Akt pathway | PMC6600559 |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.86mL 0.37mL 0.19mL |
9.29mL 1.86mL 0.93mL |
18.57mL 3.71mL 1.86mL |
Tags: Amentoflavone | Didemethyl-ginkgetin | Reactive Oxygen Species | GABA Receptor | Respiratory syncytial virus | Gamma-aminobutyric acid Receptor | γ-Aminobutyric acid Receptor | anti-inflammatory | antibacterial | apoptosis | GABA(A) modulator | cell cycle arrest | 1617-53-4
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL